热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　威高股份（01066）公布，威高骨科（688161.SH）预计 2024 年度实现归属于上市公司股东的净利润为2亿-2.4亿元，同比增加 78.07%到 113.68%；预计扣非净利约1.91亿元-2.31亿元，同比增加 77.02%到 114.09%。

　　2024 年骨科耗材带量采购全面执行进入平稳期，威高骨科积极执行带量采购政策，主动调整经营策略，重新规划产品线、优化成本控制、强化与医疗机构的合作关系，以及探索多元化市场渠道，最大限度提高市场份额和客户覆盖率，实现业绩增长。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.